NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-161-2010-0-EP-07 PROGNOSTIC MARKERS AND METHODS FOR PROSTATE CANCER EP DIV 10849985.6 Abandoned
NCI E-161-2010-0-EP-05 PROGNOSTIC MARKERS AND METHODS FOR PROSTATE CANCER EP National Stage 10849985.6 Abandoned
NCI E-161-2010-0-CA-04 PROGNOSTIC MARKERS AND METHODS FOR PROSTATE CANCER CA National Stage 2796239 Abandoned
NCI E-161-2010-0-AU-03 PROGNOSTIC MARKERS AND METHODS FOR PROSTATE CANCER AU National Stage 2010351045 Abandoned
NCI E-298-2007-0-US-04 Immunostimulatory Combination of TLR Ligands and Methods of Use US National Stage 12/679,881 9421254 Issued PDF
NCI E-017-2008-0-US-06 Compounds With MDR1-Inverse Activity US National Stage 12/867,206 Abandoned
NIA E-171-2008-0-PCT-02 Individualized Therapy Of Single Gene Disorders By Genetically Modified Adult Stem Cells PCT PCT PCT/US10/045128 Expired
NCI E-033-2011-0-US-01 METHODS OF TREATING PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH AN ANTI-CD22 IMMUNOTOXIN US 61/372,813 Abandoned
NCI E-203-2000-0-US-09 Biologically Active Macrolides, Compositions, and Uses Thereof US CON 12/851,691 8741947 Abandoned PDF
NCI E-057-1994-2-US-13 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 13/192,804 8273724 Expired PDF
NCI E-057-1994-2-US-12 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 12/851,729 8030280 Expired PDF
NIAID E-102-2008-2-US-02 Antigenic Cloaking And Its Use US National Stage 12/866,723 Abandoned
NCI E-234-2010-0-US-01 Biomarkers For Prostate Cancer And Methods For Their Detection. US 61/371,537 Abandoned
NCI E-061-2007-0-US-03 Gene Expression Profile For Predicting Ovarian Cancer Patient Survival US National Stage 12/669,894 Abandoned
NCI E-071-1992-2-JP-13 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA JP DIV 2010-176155 Abandoned
NCI E-315-2007-0-US-03 Botryllamides and Method of Inhibiting PGP in a Mammal Afflicted with Cancer US National Stage 12/811,144 8470888 Issued PDF
NCI E-263-2009-0-JP-08 Antiangiogenic Small Molecules and Methods of Use JP DIV 2014-207808 Abandoned
NCI E-263-2009-0-JP-06 Antiangiogenic Small Molecules and Methods of Use JP National Stage 2012-523106 Abandoned
NCI E-303-2003-1-US-01 Cellular and Viral Inactivation US CIP 12/847,231 8613934 Abandoned PDF
NCI E-263-2009-0-PCT-02 Antiangiogenic Small Molecules and Methods of Use PCT PCT PCT/US2010/043998 Expired
NCI E-263-2009-0-EP-05 Antiangiogenic Small Molecules and Methods of Use EP National Stage 10805140.0 Abandoned
NCI E-263-2009-0-AU-03 Antiangiogenic Small Molecules and Methods of Use AU National Stage 2010278738 Abandoned
NCI E-263-2009-0-CA-04 Antiangiogenic Small Molecules and Methods of Use CA National Stage 2769038 Abandoned
NCCIH E-148-2010-0-US-01 TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE WITH CITRUS FLAVANONES US 61/369,229 Abandoned
NICHD E-057-2008-0-JP-12 Use Of Ulipristal For Treating Uterine Fibroids JP National Stage 2010-544688 Issued
NCI E-129-2001-0-US-13 Mutuated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressi ng Leukemia Cells. US CON 12/846,625 Abandoned
NICHD E-057-2008-0-BR-05 Use Of Ulipristal For Treating Uterine Fibroids BR National Stage PI0907028-1 Issued
NICHD E-057-2008-0-MX-08 Use Of Ulipristal For Treating Uterine Fibroids MX National Stage MX/a/2010/008270 Issued
NCI E-325-2003-0-US-04 Biofunctionalized Quantum Dots For Biological Imaging US DIV 12/845,177 Abandoned
NCI E-157-2000-0-US-09 Immunogenicity Using a Combination of DNA and Vaccinia Virus Vector Vaccines US CON 12/845,350 Abandoned
NCI E-217-2010-1-US-01 A Method For The Treatment Of Obesity US 61/368,462 Abandoned
NCI E-003-2007-0-US-08 Engineered Antibody Constant Domain Molecules US National Stage 12/864,758 8580927 Issued PDF
NHLBI E-196-2010-0-US-01 Vortex Countercurrent Chromatography (VCCC) US 61/368,157 Abandoned
NCI E-058-2006-0-US-04 Lentivirus Expressing Mutant Forms On Human Thymidylate Monophosphate Kinase 9tmpk), F105Y Adn R16G Lid US CON 12/843,238 Abandoned
NICHD E-057-2008-0-IL-06 Use Of Ulipristal For Treating Uterine Fibroids IL National Stage 207182 Issued
NCI E-250-2007-0-US-04 Induced Internalization Of Surface Receptors US National Stage 12/864,492 8420620 Issued PDF
NCI E-070-2005-0-US-04 Inhibitors Of Ubiquitin E1 US DIV 12/842,346 8242160 Issued PDF
NCI E-217-2010-0-US-01 A Method for The Treatment of Obesity US 61/367,299 Abandoned
NCI E-090-2008-2-US-03 Single Nucleotide Polymorphisms Associated with Renal Disease US National Stage 12/864,218 9102983 Abandoned PDF
NIA E-141-2000-0-US-13 Agents Useful For Reducing Amyloid Precursor Protein And Treating Dementia And Methods of Use Thereof US CON 12/841,888 8258172 Expired PDF
NIAID E-184-2010-0-US-01 Use Of Dimethyloxalylglycine (N-methoxyoxoacetyl-glycine Methyl Ester, "DMOG") And Analogs As Inhibitors For Depletion Of The JMJD Family Of Enzymes To Prevent Herpes Simplex Virus Infections And Reactivation From Latency US 61/366,563 Abandoned
NINDS E-306-2003-0-AU-06 DIFFERENTIAL EXPRESSION OF MOLECULES ASSOCIATED WITH ACUTE STROKE AU DIV 2010203139 Abandoned
NCI E-307-2005-0-US-04 CYP1B1 GENOTYPE US National Stage 11/991,878 Abandoned
NCI E-230-2006-0-US-05 Pharmaceutical Composition And Method For Regulating Abnormal Cellular Proliferation US National Stage 12/085,023 8841266 Abandoned PDF
NCATS E-294-2009-0-US-01 Use Of Delta-tocopherol For The Treatment Of Lysosomal Storage Disorders (LSDs). LSDs Are A Group Of 40 To 50 Genetic Rare Diseases Caused By The Genetic Mutations Of A Number Of Lysosomal Enzymes And Proteins. US 61/365,712 Abandoned
NCI E-212-2009-0-PCT-02 Method of treating or preventing cancer PCT PCT PCT/US2010/042306 Expired
NIAID E-050-2008-3-US-01 Influenza DNA Vaccination and Methods of Use Thereof US CIP 12/838,292 Abandoned
NCATS E-187-2009-1-US-01 Organic Compounds US 61/365,152 Abandoned
NHLBI E-236-2009-0-EP-04 Emission Detection Method and System For Multi-photon Microscopy EP National Stage 10797972.6 Issued
NHLBI E-236-2009-0-DE-07 Non-Contact Total Emission Detection Method and System For Multi-photon Microscopy DE EP 10797972.6 Issued